ID: ALA3349371

Max Phase: Preclinical

Molecular Formula: C19H32O2S

Molecular Weight: 324.53

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCCCCC/C=C\C/C=C\C=C\SCCC(=O)OC

Standard InChI:  InChI=1S/C19H32O2S/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-17-22-18-16-19(20)21-2/h10-11,13-15,17H,3-9,12,16,18H2,1-2H3/b11-10-,14-13-,17-15+

Standard InChI Key:  WFASSRFUUARNKB-GVGMKTRISA-N

Associated Targets(non-human)

Arachidonate 5-lipoxygenase 2865 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 324.53Molecular Weight (Monoisotopic): 324.2123AlogP: 6.05#Rotatable Bonds: 14
Polar Surface Area: 26.30Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 6.09CX LogD: 6.09
Aromatic Rings: 0Heavy Atoms: 22QED Weighted: 0.17Np Likeness Score: 1.22

References

1. Hanko R, Hammond MD, Fruchtmann R, Pfitzner J, Place GA..  (1990)  Design, synthesis, and 5-lipoxygenase-inhibiting properties of 1-thio-substituted butadienes.,  33  (4): [PMID:2319562] [10.1021/jm00166a013]

Source